Tender detail
Professional liability insurance for the La Paz clinical trial of intranasal T-cell therapy
Summary
The Biomedical Research Foundation of La Paz University Hospital is procuring one professional civil-liability insurance policy for a Phase I clinical trial assessing an intranasal allogeneic T-cell therapy for hospitalised children with confirmed respiratory syncytial virus or influenza infection. The study has two groups of 20 patients, for an estimated total of 40, and the contract includes an additional 24-month notification period. The policy covers liability for harm to trial participants, related compensation and legal costs, court-required guarantees, and specified risks including hepatitis C and HIV infection and certain development risks.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.